Clinical Trial Update: Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia [Phase 3]

View source ↗

Summary

Phase 3 trial update for iron oligosaccharide in subjects with inflammatory bowel disease and iron deficiency anemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Iron Deficiency Anemia

Drugs mentioned

• Iron Oligosaccharide (iron oligosaccharide)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Inflammatory Bowel Disease | Phase 3 | Status: COMPLETED